A specific group of multiple sclerosis patients can now be reimbursed for stem cell transplants from the basic mandatory health insurance package, the National Health Care Institute announced. These are patients with the relapsing remitting MS who cannot necessarily be helped with medication. "For these patients, stem cell transplantation is sufficiently proven to be effective care," the Institute said. The decision affects ten to twenty patients per year and is effective immediately. - READ MORE

By NL Times

Wed, 14 Dec 2022 18:06:00 GMT